Filing Details

Accession Number:
0001144204-18-064217
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-12 13:15:38
Reporting Period:
2018-12-03
Accepted Time:
2018-12-12 13:15:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595327 Jeffrey Paley C/O Avenue Therapeutics, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-03 10,000 $5.48 74,663 No 4 P Direct
Common Stock Acquisiton 2018-12-10 5,000 $4.76 79,663 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on December 3, 2018 was $5.4734 to $5.4774. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Includes 64,663 shares of restricted stock.